Quarterly report · Q2
3939.TEDINET S100TDG1
Period2023-10-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.4bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥3.7bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥669m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥559m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥675m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥565m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥684m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥588m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥763m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥406m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥406m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥5.6bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥5.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥6.5bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.5bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥3.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.8bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.6bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥438m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥339m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥194m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥842m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥242m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥434m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.3bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥405m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥9.65 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.27 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.08 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.55 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.06 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥15.58 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥8.09 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 60.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥21m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥15m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥641m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥285m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥281m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥4m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥690m |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥52,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥52,000 |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥3m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥384m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥384m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥10m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥52,000 |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥553m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥52,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-03-31 | ¥563m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 539
| Item | Context | Value | Unit |
|---|---|---|---|
| Investments and other assets | Prior1YearInstant | 320972000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 306615000 | JPY |
| Noncurrent assets | Prior1YearInstant | 2419258000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 2465906000 | JPY |
| Assets | Prior1YearInstant | 5653058000 | JPY |
| Assets | CurrentQuarterInstant | 5606868000 | JPY |
| Accounts payable trade | Prior1YearInstant | 50790000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 114709000 | JPY |
| Current portion of bonds | Prior1YearInstant | 60000000 | JPY |
| Current portion of bonds | CurrentQuarterInstant | 60000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 280956000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 285738000 | JPY |
| Lease obligations cl | Prior1YearInstant | 7482000 | JPY |
| Lease obligations cl | CurrentQuarterInstant | 6625000 | JPY |
| Accounts payable other | Prior1YearInstant | 136796000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 135088000 | JPY |
| Accrued expenses | Prior1YearInstant | 74436000 | JPY |
| Accrued expenses | CurrentQuarterInstant | 73891000 | JPY |
| Income taxes payable | Prior1YearInstant | 207026000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 231991000 | JPY |
| Accrued consumption taxes | Prior1YearInstant | 97792000 | JPY |
| Accrued consumption taxes | CurrentQuarterInstant | 65062000 | JPY |
| Contract liabilities | Prior1YearInstant | 368273000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 234529000 | JPY |
| Deposits received | Prior1YearInstant | 30721000 | JPY |
| Deposits received | CurrentQuarterInstant | 22625000 | JPY |
| Provision for bonuses | Prior1YearInstant | 55938000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 57143000 | JPY |
| Asset retirement obligations cl | Prior1YearInstant | 16000000 | JPY |
| Asset retirement obligations cl | CurrentQuarterInstant | 16000000 | JPY |
| Other cl | Prior1YearInstant | 19646000 | JPY |
| Other cl | CurrentQuarterInstant | 16759000 | JPY |
| Current liabilities | Prior1YearInstant | 1405859000 | JPY |
| Current liabilities | CurrentQuarterInstant | 1320164000 | JPY |
| Bonds payable | Prior1YearInstant | 65000000 | JPY |
| Bonds payable | CurrentQuarterInstant | 35000000 | JPY |
| Long term loans payable | Prior1YearInstant | 859524000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 719724000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 6060000 | JPY |
| Lease obligations ncl | CurrentQuarterInstant | 3211000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 58410000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 65434000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 82454000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 88030000 | JPY |
| Other ncl | Prior1YearInstant | 800000 | JPY |
| Other ncl | CurrentQuarterInstant | 800000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1072249000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 912199000 | JPY |
| Liabilities | Prior1YearInstant | 2478109000 | JPY |
| Liabilities | CurrentQuarterInstant | 2232364000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |